1.
Clin Infect Dis
; 57(9): 1300-3, 2013 Nov.
Artículo
en Inglés
| MEDLINE
| ID: mdl-23840000
RESUMEN
Nephrotoxicity was assessed in 173 critically ill patients receiving intravenous colistin or polymyxin B; it occurred in 60.4% and 41.8%, respectively. Further investigation is necessary to elucidate the reason for the difference in nephrotoxicity observed between the groups and to assess the impact of severity of illness and dosing/administration.